BDO's AI professionals offer an inside look at how AI tools drive business.
Adapt, scale, and perform more effectively with the right operating model.
Explore IRS rules that may impact tax-exemption for schools.
Explore findings on AI adoption, governance, data readiness and more in healthcare.
Review what the temporary halt for the Uniform Guidance rewrite could mean.
Delve into the evolution of public sector governance and oversight.
A board-level perspective on the evolving cyber and data protection landscape.
Listen to timely conversations on the tax issues shaping today's business landscape.
Discover strategies for strengthening referral capture before patients' appointments.
Learn about BDO's sustainability journey, strategies, and programs.
Read about the 10 accounting students awarded scholarships.
Explore a BDO employee's journey of service with nonprofits.
Digital transformation is more than a technology story.
Showing 1-10 of 19 insights
Michigan’s RAB 2026-4 explains how to claim the state R&D credit, with rules that differ for CIT taxpayers and flow-through entities. Learn what applies for 2025 expenses, filing deadlines, and MQRE calculation requirements.
Read More chevron_right
Explore what lies ahead for life sciences in the 2025 Life Sciences CFO Outlook Survey.
Explore the report to see how you compare to your competitors and gain valuable insights to support strategic decision-making and turn your challenges into triumphs. Download the report today.
Read More open_in_new
The 2024 Life Sciences CFO Outlook Survey provides a glimpse into what your competitors are anticipating for the upcoming year. Download the report today.
Want to take your healthcare organization’s tax planning to the next level? Read the insight insight to learn about available tax credits and incentives.
Read the 2023 BDO Life Sciences CFO Outlook Survey to see what the industry’s CFOs are doing to conserve cash — and what those decisions could mean for your company going forward.
Join BDO’s Governance, Risk and Compliance team for a webinar series to learn more about how we help companies address their performance, regulatory compliance and governance challenges, which can impact leaders from the Board of Directors to the General Counsel and executive team.
When acquiring a company, you don’t want bribery, fraud and corruption to come along with it — especially if you’re in the life sciences sector, which is among the most highly regulated industries in the world.
Data is the lifeblood of life sciences—it’s the key ingredient in developing new drugs and therapies to improve quality of life and treat illness.
Nothing returns to normal without life sciences. Tasked with charting a sustainable road to recovery for both the industry and the global economy at large, life sciences CFOs feel confident about the pivots they made in crisis and are optimistic for growth in 2021.
Didn't find what you're looking for? Explore Advanced Search